Form 4: OraSure Technologies CEO Receives Stock Award and Pays Taxes with Shares

Sentiment:

SEC Form 4 Filing


Carrie Eglinton Manner, President & CEO of OraSure Technologies, received a restricted stock award and used shares to cover tax liabilities.

Summary

  • Carrie Eglinton Manner, the President and CEO of OraSure Technologies, received a grant of 462,414 shares of restricted stock on March 1, 2025.
  • These shares vest in three equal annual installments starting March 1, 2026, contingent upon continuous service.
  • Also on March 1, 2025, 62,382 shares were withheld to cover the tax liability associated with the vesting of restricted shares at a price of $3.6275 per share.
  • Following these transactions, Ms. Eglinton Manner beneficially owns 1,688,366 shares of OraSure Technologies stock.

Sentiment

Score: 7

Explanation: The document reflects standard executive compensation practices, which are generally viewed neutrally to positively as they align management with shareholder interests.

Positives

  • The grant of restricted stock aligns the CEO's interests with those of the shareholders, incentivizing long-term performance.

Future Outlook

The restricted stock award vests over three years, incentivizing the CEO's continued service and contribution to the company's long-term success.

Industry Context

Stock awards are a common form of executive compensation in the biotechnology industry, aligning management's interests with shareholder value.

Comparison to Industry Standards

  • Stock awards are a typical component of executive compensation packages in publicly traded companies, particularly in the technology and healthcare sectors.
  • Companies like Abbott Laboratories and Danaher Corporation also utilize stock awards as part of their executive compensation strategy.
  • The vesting schedule of three years is also fairly standard, aligning with typical long-term incentive plans.

Stakeholder Impact

  • Shareholders may view the stock award positively as it incentivizes the CEO to drive long-term value.
  • Employees may see the award as a sign of confidence in the company's future.

Key Dates

DateDescription
03/01/2025Date of restricted stock award and tax withholding.
03/01/2026First vesting date for the restricted stock award.
03/04/2025Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.